These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 163152)

  • 21. Dissociations between changes in myocardial cyclic adenosine monophosphate and contractility.
    Henry PD; Dobson JG; Sobel BE
    Circ Res; 1975 Mar; 36(3):392-400. PubMed ID: 163151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of cyclic adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate and theophylline on renin secretion in the isolated perfused kidney of the rat.
    Peart WS; Quesada T; Tenyi I
    Br J Pharmacol; 1975 May; 54(1):55-60. PubMed ID: 166719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of adrenergic agents on alpha-amylase release and adenosine 3',5'-monophosphate accumulation in rat parotid tissue slices.
    Butcher FR; Goldman JA; Nemerovski
    Biochim Biophys Acta; 1975 May; 392(1):82-94. PubMed ID: 164957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of glucagon on renin secretion in the dog.
    Ueda J; Nakanishi H; Abe Y
    Eur J Pharmacol; 1978 Nov; 52(1):85-92. PubMed ID: 214314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting effects of hypoglycemia on plasma renin activity and cyclic adenosine 3',5'-monophosphate (cyclic AMP) in low renin and normal renin essential hypertension.
    Lowder SC; Hamet P; Liddle GW
    Circ Res; 1976 Feb; 38(2):105-8. PubMed ID: 173476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditions for augmentation of renin release by theophylline.
    Langård O; Holdaas H; Eide I; Kiil F
    Scand J Clin Lab Invest; 1983 Feb; 43(1):9-14. PubMed ID: 6312554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamine and dibutyryl cyclic AMP effects on myosin adenosine triphosphatase in cultured rat heart cells.
    Harary I; Hoover F; Farley B
    Science; 1973 Sep; 181(4104):1061-3. PubMed ID: 4146909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.
    Ball JH; Kaminsky NI; Hardman JG; Broadus AE; Sutherland EW; Liddle GW
    J Clin Invest; 1972 Aug; 51(8):2124-9. PubMed ID: 4403383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased release of cyclic adenosine monophosphate into jugular vein in response to isoproterenol administration.
    Altszuler N; Friedman E; Laschinger JC; Catinella FP; Cunningham JN; Nathan IM
    Life Sci; 1984 Aug; 35(9):963-7. PubMed ID: 6088934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of atriopeptin III on renin release in vitro.
    Henrich WL; Needleman P; Campbell WB
    Life Sci; 1986 Sep; 39(11):993-1001. PubMed ID: 3018407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of detectable change in cyclic AMP during the cardiac inotropic response to isoproterenol immobilized on glass beads.
    Venter HC; Ross J; Kaplan NO
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):824-8. PubMed ID: 165489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of antilipolytic agents on cyclic AMP, free fatty acid and total catecholamine concentrations in plasma.
    Strange RC; Rowe MJ; Mjos OD; Oliver MF
    Acta Med Scand; 1976; 199(5):421-4. PubMed ID: 179286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium administration and phosphate excretion.
    Arruda JA; Richardson JM; Wolfson JA; Nascimento L; Rademacher DR; Kurtzman NA
    Am J Physiol; 1976 Oct; 231(4):1140-6. PubMed ID: 185911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenergically induced renin release in conscious indomethacin-treated dogs and rats.
    Seymour AA; Davis JO; Echtenkamp SF; Dietz JR; Freeman RH
    Am J Physiol; 1981 Jun; 240(6):F515-21. PubMed ID: 7018258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catecholamine induced increase of cyclic adenosine 3',5'-monophosphate in rat brain in vivo.
    Burkard WP
    J Neurochem; 1972 Nov; 19(11):2615-9. PubMed ID: 4343752
    [No Abstract]   [Full Text] [Related]  

  • 37. Species differences in the effect of isoproterenol and pindolol on renin release in vitro.
    Gaál K; Mózes T
    Acta Physiol Acad Sci Hung; 1979; 54(2):109-13. PubMed ID: 396760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the renin-angiotensin system in mediation of adrenal catecholamine secretion in the cat induced by intrarenal beta-adrenergic stimulation.
    Krausz MM; Feuerstein G; Feuerstein N; Gutman Y
    Circ Res; 1980 Dec; 47(6):835-9. PubMed ID: 7002344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective A1 adenosine receptor antagonism augments beta-adrenergic-induced renin release in vivo.
    Pfeifer CA; Suzuki F; Jackson EK
    Am J Physiol; 1995 Oct; 269(4 Pt 2):F469-79. PubMed ID: 7485531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversible resistance to the phosphaturic effect of db-cAMP in lithium-treated rats.
    Angielski S; Drewnowska K; Rybczyńska A; Szczepańska-Konkel M
    Acta Physiol Pol; 1982; 33(5-6):463-74. PubMed ID: 6312743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.